Ciclosporin regulatory update

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for Allergan's ciclosporin to treat atopic keratoconjunctivitis. The cyclosporine 0.010...